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Introduction: Bone marrow mesenchymal stem cells (BMSCs) possess low immunogenicity and
immunosuppression as an allograft, can differentiate into insulin-producing cells (IPCs) by in vitro induction, and
may be a valuable cell source to regenerate pancreatic islets. However, the very low differentiation efficiency of
BMSCs towards IPCs under adherent induction has thus far hindered the clinical exploitation of these cells. The aim
of this study is to explore a new way to efficiently induce BMSCs into IPCs and lay the groundwork for their clinical
exploitation.
Methods: In comparison with adherent induction, BMSCs of human first-trimester abortus (hfBMSCs) under a nonadherent
state were induced towards IPCs in noncoated plastic dishes using a three-stage induction procedure developed by the
authors. Induction effects were evaluated by statistics of the cell clustering rate of induced cells, and ultrastructural
observation, dithizone staining, quantitative polymerase chain reaction and immunofluorescence assay, insulin
and c-peptide release under glucose stimulus of cell clusters, as well as transplantation test of the cell clusters in
diabetic model mice.
Results: With (6.175 ± 0.263) × 105 cells in 508.5 ± 24.5 cell clusters, (3.303 ± 0.331) × 105 single cells and
(9.478 ± 0.208) × 105 total cell count on average, 65.08 ± 2.98% hfBMSCs differentiated into pancreatic islet-like
cell clusters after nonadherent induction. With (3.993 ± 0.344) × 105 cells in 332.3 ± 41.6 cell clusters, (5.437 ± 0.434) × 105
single cells and (9.430 ± 0.340) × 105 total cell count on average, 42.37 ± 3.70% hfBMSCs differentiated into pancreatic
islet-like cell clusters after adherent induction (P < 0.01, n = 10). The former is significantly higher than the latter.
Calculated according to the cell clustering rate and IPC percentage in the cell clusters, 29.80 ± 3.95% hfBMSCs
differentiated into IPCs after nonadherent induction and 18.40 ± 2.08% hfBMSCs differentiated into IPCs after adherent
induction (P < 0.01, n= 10), the former significantly higher than the latter. The cell clusters expressed a broad gene profile
related to pancreatic islet cells, released insulin and c-peptide in a glucose concentration-dependent manner, and
normalized hyperglycemia of streptozocin-induced mice for at least 80 days following xenograft. Blood glucose
of grafted mice rose again after their graft removed. A series of examination of the grafts showed that transplanted
cells produced human insulin in recipients.
Conclusions: Our studies demonstrate that nonadherent induction can greatly promote BMSCs to form pancreatic
islet-like cell clusters, thereby improving the differentiation efficiency of BMSCs towards IPCs.* Correspondence: zyh19620207@163.com
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Type 1 diabetes (insulin-dependent diabetes mellitus), with
an annual net rise of about 3% in incidence [1], results from
the autoimmune lesion of pancreatic beta-cells. Insulin-
dependent diabetes mellitus has been successfully treated by
transplantation with pancreatic islets of Langerhans [2,3],
but further application of this therapy is limited by the lack
of Langerhans donors and immunological rejection. Fortu-
nately, bone marrow mesenchymal stem cells (BMSCs) not
only differentiate into multiple mesodermal and nonmeso-
dermal cell lineages including insulin-producing cells (IPCs)
[4-11], but also possess low immunogenicity [12] and im-
munosuppression by modulating the immune function of
the major cell populations involved in alloantigen recogni-
tion and elimination [13-21]. These unique biological prop-
erties make BMSCs a promising source for cell replacement
of kinds of tissue necrosis and function cell exhaustion, es-
pecially insulin-dependent diabetes mellitus.
Under adherent induction, however, BMSCs are not
effective to form cell clusters, leading to the very low
differentiation efficiency of BMSCs towards IPCs. We
hypothesized that nonadherent induction favors the
formation of cell clusters, thereby improving the differ-
entiation efficiency of BMSCs towards IPCs. To verify
this hypothesis, we induced BMSCs of human first-
trimester abortus (hfBMSCs) under a nonadherent state
to efficiently differentiate into functional islet-like cell
clusters, which corrected hyperglycemia in model mice
following xenograft. This study provides a new way to in-




Under permission of the patients, a local hospital and the
Ethics Committee of Northwest A & F University, hfBMSCs
were isolated from long bones of 2-month-old to 3-
month-old human abortuses using whole-marrow cell cul-
ture and proliferated in α-modified Eagle’s medium (Gibco,
Billings, Montana, USA), 10% fetal calf serum (Stemcell
Technologies Inc., Vancouver, British Columbia, Canada)
and 0.1 mmol/l β-mercaptoethanol (Sigma Loveland, CO,
USA). The cells were identified using flow cytometry
(Beckman Coulter Inc., Fullerton, California, USA) and
CD29, CD44, CD166, CD11a, CD14 and CD34 fluorescence-
tagged antibodies (Beckman Coulter Inc.).
In vitro induction of hfBMSCs towards insulin-producing
cells
Passage 6 of the cryopreserved hfBMSCs was thawed, and
proliferated to passage 8 in α-modified Eagle’s medium,
20% fetal calf serum, and 0.1 mmol/l β-mercaptoethanol.
Passage 8 of hfBMSCs underwent acclimation in
Dulbecco’s modified Eagle’s medium (DMEM)–highglucose (containing 25 mmol/l glucose; HyClone, Logan,
Utah, USA), 10% fetal calf serum, and 0.1 mmol/l β-
mercaptoethanol, were digested, were transferred into
noncoated plastic dishes (in which hfBMSCs are nonad-
herent), and were induced using a three-stage induction
procedure developed by the authors. This procedure was
respectively performed 10 times using hfBMSCs from dif-
ferent abortus (n = 10), with nine replications each and
each replication covering one dish containing more than
1 × 106 hfBMSCs, as the nonadherent induction group.
The same hfBMSCs were transferred into lysine-coated
plastic dishes (in which hfBMSCs are adherent) and in-
duced using the same procedure (n = 10) as the adherent
induction group.
In stage one of the procedure, the hfBMSCs were cul-
tured for 6 days to develop nestin-positive cells with
DMEM–high glucose plus 10 ng/ml basic fibroblast
growth factor (Invitrogen, Carlsbad, California, USA),
10 ng/ml epidermal growth factor (EGF; Chemicon,
California, USA), 2% B27 supplement (Stemcell
Technologies Inc.), 0.5% bovine serum albumin (BSA;
Invitrogen), and 0.1 mmol/l β-mercaptoethanol, with
medium changes every 2 days. Stage two differentiated
nestin-positive cells into IPCs via a 6-day induction with
DMEM–high glucose plus 10 ng/ml EGF, 20 ng/ml
Activin A (Sigma), 10 mmol/l nicotinamide (Sigma), 2%
B27, 0.5% BSA, and 0.1 mmol/l β-mercaptoethanol, with
medium changes every 2 days. Stage three was the matur-
ation of the expected IPCs via a 4-day culture with
DMEM–low glucose (containing 5.6 mmol/l glucose;
Gibco) plus 10 ng/ml EGF, 10 nmol/l exendin-4 (Sigma),
10 ng/ml betacellulin (Sigma), 2% B27, 0.5% BSA, and
0.1 mmol/l β-mercaptoethanol, with medium changes
every 2 days.
Statistics of the cell clustering rate
After each time induction, one dish was picked out
randomly, cell clusters and single cells in the dishes
were collected respectively, and cells from the cell
clusters and the single cells were counted respectively.
The cell clustering rate was calculated according to
the cell number in the cell clusters divided by the
summation of the single cells and cells in the cell clus-
ters (n = 10), and the average cell number of each cell
cluster was calculated according to the cell number in
the cell clusters divided by the cell cluster number
(n = 10).
Ultrastructural observation of endocrine cells in cell
clusters
After each time induction, one dish was randomly
picked from the nonadherent induction group and the
adherent induction group (n = 10). The cell clusters were
centrifuged for 10 minutes, fixed in 0.1% glutaraldehyde/
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ferred to 0.1 mol/l cacodylate buffer, and embedded.
Ultrathin sections were prepared, observed and photo-
graphed under a transmission electron microscope
(H-7650; Hitachi, Japan). Fetal pancreatic islets, newly
isolated from the pancreas of human abortus at the age
of 20 weeks according to Kover and Moore [22], were
used as the positive control.Dithizone staining
After each time induction, one dish was randomly picked
from the nonadherent induction group and the adherent
induction group and cell clusters were collected respect-
ively (n = 10). The cell clusters, non-induced hfBMSCs
(as non-induction control), and some fetal pancreatic is-
lets (as positive control) were stained for 15 minutes with
a freshly prepared dithizone (Sigma) working solution at
37°C, washed three times with phosphate-buffered sa-
line (PBS), observed and photographed under an optical
microscope.Table 1 Human gene-specific primers and quantitative polym
Gene Primer sequence (5′ to 3′) Size of PCR pro
18SrRNA Forward: CGGCTACCACATCCAAGGAA 1
Reverse: GCTGGAATTACCGCGGCT
Pdx1 Forward: TTCCGGAAGAAAAAGAGCCA 1
Reverse: AAACAGGTCCCAAGGTGGAGT
Ngn3 Forward: CGCAATCGAATGCACAACCT 1
Reverse: TTGAGTCAGCGCCCAGATGTA
Pax4 Forward: ATTCAGTGGCCCGTGGAAA 1
Reverse: TCTCTTGCCGACGCCATTT
NeuroD1 Forward: TCTTTCAAACACGAACCGTCC 1
Reverse: AGATTGATCCGTGGCTTTGG
Nkx2.2 Forward: GCCACGAATTGACCAAGTGAA 1
Reverse: ATGTCCTTGACCGAAAACCCC
Nkx6.1 Forward: ACACGAGACCCACTTTTTCCG 1
Reverse: AATAGGCCAAACGAGCCCTCT
PCSK1 Forward: TCCTCTTTTGCGCTTGGTGT 1
Reverse: TGACCCAAAAGGTCATAGCCC
Insulin Forward: GCGTGGCATTGTGGAACAA 1
Reverse: CCATCTCTCTCGGTGCAGGA
Glucagon Forward: ACATTGCCAAACGTCACGATG 1
Reverse: GCAATGAATTCCTTGGCAGCT
SST Forward: GAAGCAGGAACTGGCCAAGTA 1
Reverse: CCTCATTTCATCCTGCTCAGC
PP Forward: ACAATGCCACACCAGAGCAGA 1
Reverse: GGCCAGCGTGTCCTCTTTG
PCR, polymerase chain reaction.Fluorescent quantitative reverse transcriptase-polymerase
chain reaction assay
To clarify the in vitro expression levels of pdx1, ngn3,
pax4, neuroD1, nkx2.2, nkx6.1, PCSK1, insulin, gluca-
gon, SST, and PP genes in induced cells, fluorescent
quantitative reverse transcriptase-polymerase chain reac-
tion was performed. Total RNA of cell clusters from
each time induction in the nonadherent induction group
and the adherent induction group, fetal pancreatic islets
as positive control and non-induced hfBMSCs as non-
induction control were extracted with TRlzol® Reagent
(Invitrogen) and each was reverse-transcribed into
cDNA with the PrimerScript RT reagent kit (TaKaRa,
Tokyo, Japan) according to the manufacturer’s manual
(n = 10). The forward and reverse primers and the fluor-
escent quantitative polymerase chain reaction details for
the marker genes in this study are presented in Table 1.
Immunofluorescence assay
To test the expression of nestin, insulin and c-peptide dur-
ing the induction, cell clusters were sampled individuallyerase chain reaction conditions
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paraformaldehyde for 20 to 30 minutes, triple-washed
with PBS, and stained with mouse antibodies against
human nestin (Abcam, Cambridge, Massachusetts, UK)
and insulin (Invitrogen), and rabbit anti-human c-peptide
antibody (Abcam), and then with secondary fluorescent
antibodies including fluorescein isothiocyanate-conjugated
donkey anti-mouse IgG and Alexa Flour 594-conjugated
goat anti-rabbit IgG (Invitrogen). To investigate the ex-
pression rate of IPCs and other endocrine cells in cell
clusters, the cell clusters from each time induction were
respectively digested, subcultured for 24 hours in a lysine-
coated 24-well plate before fixation, stained with mouse
anti-human insulin and glucagon, rabbit anti-human SST
and PP antibodies (Invitrogen), and the relevant IgGs con-
jugated with fluorescence. Ten nonoverlapping visual
fields were randomly chosen from each staining sample to
count stained and nonstained cells under microscopy, and
they were photographed using an inverted microscope.
The proportion of cells immunoreactive to particular anti-
gens was quantified according to the stained cell number
divided by the summation number of stained cells and
nonstained cells (n = 10).
In vitro insulin and c-peptide release in response to increasing
glucose concentrations
After each time induction, cell clusters were sampled
from the nonadherent induction group and the adherent
induction group respectively, transferred into 12-well
culture plates containing a lysine coating for cells to at-
tach, 100 clusters per well, and were precultured in
DMEM–low glucose, 10 ng/ml EGF, 2% B27, 0.5% BSA,
and 0.1 mmol/l β-mercaptoethanol for 24 hours, washed
three times with PBS, and stimulated with 1 ml of either
5, 10, or 25 mmol/l glucose in PBS containing 1% BSA
(n = 10). In parallel, 100 fetal pancreatic islets (positive
control) and 1.2 × 105 hfBMSCs at passage 8 (equivalent
to 100 cell clusters, non-induction control) were treated
in the same way with all three glucose levels. The super-
natants from all treatments were collected after 30 minutes
of stimulation, and insulin and c-peptide were measured
via radioimmunoassay with the human insulin-specific RIA
kit and the human c-peptide RIA kit (LINCO Research
Inc., St. Charles, MO, USA) and a liquid scintillation
counter (LS6000; Beckman Co., USA).
Preparation of type 1 diabetic model mice
Approved by the Institutional Animal Care and Use
Committee of Northwest A & F University, a total of 35
adult male nude mice (BALB/c nu/nu), provided by the
Experiment Animal Centre of the Fourth Military
Medical University (Xi’an, China), each with normal
blood glucose levels, were administered daily intraperito-
neal injections of 50 mg/kg streptozocin (STZ; Sigma)for 5 consecutive days. At 72 hours after the last STZ in-
jection, fasting blood glucose levels were determined
using a standard blood glucose meter (Sure Step™ Plus;
LifeScan Inc., Milpitas, CA, USA) once a day for 3 con-
secutive days. If the three fasting blood glucose levels
were all higher than 18 mmol/l, the mouse was used as a
diabetic model animal for our experiments.Transplantation of CM-DiI-labeled cell clusters to treat
diabetic mice
Cell clusters from the nonadherent induction group
and the adherent induction group, and also non-induced
hfBMSCs, were incubated individually in a working solu-
tion of Cell Tracker–CM-DiI (Molecular Probes, Invitrogen
Carlsbad, California, USA) for 5 minutes at 37°C and
for another 15 minutes at 4°C according to the manu-
facturer’s instructions, followed by washing with PBS,
and were checked under a fluorescence microscope.
The 600 CM-DiI-labeled cell clusters from the nonadher-
ent induction (about 7.2 × 105 cells) were transplanted
into the right-side testis of 10 diabetic model mice each
as the nonadherent induction group (n = 10). The 600
CM-DiI-labeled cell clusters from the adherent induction
were transplanted into the right-side testis of another
10 diabetic model mice each as the adherent induction
group (n = 10). CM-DiI-labeled but non-induced 7.2 × 105
hfBMSCs were transplanted into the right-side testis
of another six diabetic model mice each as the non-
induction control group (n = 6). Blood glucose levels of
animals in each of the three treatments were measured
once every 4 days using a standard blood glucose meter
and the body weight was measured once every 8 days
using an electronic balance (Mettler-Toledo Inc., Columbus,
OH, USA).
To examine the effects of graft removal on the blood
glucose fluctuation and the survival situation of the re-
cipients, and the in situ insulin production of the xeno-
grafts, three mice were randomly selected from each
animal group and their right testes removed 28 days post
transplantation following similar blood glucose and body
weight measurements. Histological sections of all tes-
ticular grafts were dewaxed and stained with mouse
monoclonal antibodies against human insulin and then
with fluorescein isothiocyanate-conjugated donkey anti-
mouse IgG, and were examined using a fluoroscope.
To evaluate the glucose clearance effects of the trans-
planted islet-like cell clusters, the intraperitoneal glucose
tolerance test was performed on five mice in each of the
nonadherent induction group and the adherent induc-
tion group after 12 days of glucose level normalization
following the transplantation and on five nondiabetic
mice (as normal control). Each mouse was intraperitone-
ally injected with glucose at 2 mg/g body weight under
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60, 90, 120, and 150 minutes thereafter [23].Data processing
Data are treated for significance with Student’s t test or
SPSS 12.0 simplified Chinese version one-way analysis of
variance where applicable. In all cases, all values are pre-
sented as mean ± standard deviation and P < 0.05 was
considered significant.Results
Preparation of hfBMSCs
The whole-marrow cell culture resulted in spindle cell
adherence (Figure 1A). Many spindle cells then clonally
grew and spread at the bottom of a culture dish within
the 12th day (Figure 1B). Several hundred dishes of
sixth-passage cells (about 106 cells in every dish) were
obtained upon continuously passaging culture and were
cryopreserved in liquid nitrogen. Flow cytometric ana-
lysis showed that passage 6 of the isolated cells strongly
expressed the surface markers of mesenchymal stem
cells, such as CD29, CD44 and CD166, but almost no
markers of Hematopoietic Stem Cells, such as CD11a,
CD14 and CD34 (Figure 1C).Figure 1 Isolation and identification of bone marrow
mesenchymal stem cells of human first-trimester abortus.
Adhered spindle cells appeared in culture of whole bone marrow
(A) and they clonally grew and spread at the bottom of a culture dish
within the 12th day (B). Flow cytometric analysis showed that passage
6 of the isolated cells strongly expressed the surface markers of
mesenchymal stem cells, such as CD29, CD44 and CD166, but almost
no markers of Hematopoietic Stem Cells, such as CD11a, CD14 and
CD34 (C). FITC, fluorescein isothiocyanate; PE, phycoerythrin.Differentiation of hfBMSCs into islet-like cell clusters
In the first-stage induction, most hfBMSCs in the non-
adherent induction group congregated on the dish bot-
toms to gradually form many irregular cell clusters
(Figure 2A), whereas a few cells died and floated on the
medium surface. Comparatively, less than one-half of
the hfBMSCs in the adherent induction group congre-
gated into irregular cell clusters adhering to the dish
bottom (Figure 2E). In the second-stage induction, the
cell clusters in the nonadherent induction group gradually
became compact (Figure 2B), whereas the cell clusters in
the adherent induction group became hemispherical and
firmly adhered to the dish bottom (Figure 2F). In the
third-stage induction, the cell clusters in the nonadherent
induction group gradually became spherical with blurred
boundaries between adjacent cells on the surface, similar
to the morphology of the islets of Langerhans, whereas
some of the nonclustered cells adhered to the dish bottom
and became similar to hfBMSCs in shape (Figure 2C,D).
Comparatively, the cell clusters in the adherent induction
group gradually uplifted but still adhered to the dish bot-
tom, with blurred boundaries between adjacent cells on
the surface (Figure 2G,H).
With (6.175 ± 0.263) × 105 cells in 508.5 ± 24.5 cell clus-
ters, (3.303 ± 0.331) × 105 single cells, (9.478 ± 0.208) × 105
total cell count and 1,215.07 ± 35.38 cells in each cluster
on average, 65.08 ± 2.98% hfBMSCs differentiated into
pancreatic islet-like cell clusters in the nonadherent induc-
tion group (n = 10). With (3.993 ± 0.344) × 105 cells in
332.3 ± 41.6 cell clusters, (5.437 ± 0.434) × 105 single cells,
(9.430 ± 0.340) × 105 total cell count and 1,199.36 ± 63.41
cells in each cluster on average, 42.37 ± 3.70% hfBMSCs
differentiated into pancreatic islet-like cell clusters in the
adherent induction group (n = 10). The former is signifi-
cantly higher than the latter (P < 0.01, n = 10). However,
the total cell count and average cell number of each cell
cluster are not significantly different between the nonad-
herent induction group and the adherent induction group
(P > 0.05, n = 10). Under transmission electron micros-
copy, a large number of endocrine cells (Figure 2I) and se-
cretion granules in cytoplasma were observed in the
sections of islet-like cell clusters in the nonadherent in-
duction group (Figure 2J) and the adherent induction
group (Figure 2K), which were histologically similar to
those in fetal pancreatic islets as a positive control
(Figure 2L).
Dithizone staining
Dithizone is a zinc-chelating agent used to selectively
stain pancreatic beta-cells crimson red. The insulin pro-
duction of the islet-like cell clusters was verified by posi-
tive dithizone staining in the nonadherent induction
group (Figure 3A.a) and the adherent induction group
(Figure 3A.b), similar to staining behavior of fetal pancreatic
Figure 2 Differentiation of bone marrow mesenchymal stem cells of human first-trimester abortus into islet-like cell clusters. Many
irregular cell clusters formed in the first-stage induction (A), became compact in the second-stage induction (B), and became spherical with
blurred boundaries among adjacent cells in the third-stage induction, similar to the morphology of the islets of Langerhans, whereas some of the
nonclustered cells adhered to the dish bottom and became similar to bone marrow mesenchymal stem cells of human first-trimester abortus in
shape in the nonadherent induction group (C), (D). Irregular cell clusters after the first-stage induction (E) became hemispherical in the second-stage
induction (F), uplifted with blurred boundaries among adjacent cells in the third-stage induction in the adherent induction group (G), (H), and always
adhered to the dish bottom. Transmission electron microscopy showing a large number of endocrine cells (I) and secretion granules in cytoplasma of
the cells in the cell clusters from the nonadherent induction group (J) and the adherent induction group (K) after the three-stage induction,
histologically similar to those in fetal pancreatic islets as the positive control (L).
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negative for dithizone (Figure 3A.d).
Fluorescent quantitative reverse transcriptase-polymerase
chain reaction
Fluorescent quantitative reverse transcriptase-polymerase
chain reaction (Figure 3B) showed that the islet-like cell
clusters in the nonadherent induction group and the ad-
herent induction group all expressed pdx1, ngn3, pax4,
neuroD1, nkx2.2, nkx6.1, PCSK1, insulin, glucagon, SST
and PP, similar to the expression profile of fetal pancreatic
islets. However, the islet-like cell clusters in the nonadher-
ent induction group and the adherent induction group
expressed significantly more Ngn3 and Pax4, and signifi-
cantly less insulin, glucagon, SST and PP than fetal pan-
creatic islets (all P < 0.01, n = 10), indicating that the cell
clusters from hfBMSCs induced in vitro were not mature
enough. The expression of the genes was similar betweenthe nonadherent induction group and the adherent induc-
tion group.
Immunofluorescence assay
The immunofluorescence assay indicated that the islet-like
cell clusters from the nonadherent induction group and
the adherent induction group all expressed nestin, insulin
and c-peptide (Figure 4); that is, nestin was more expressed
after the first-stage induction in the nonadherent induction
group (Figure 4A,B,C) and the adherent induction group
(Figure 4D,E,F), and insulin and c-peptide more expressed
after the third-stage induction in the nonadherent induc-
tion group (Figure 4G,H,I,J) and the adherent induction
group (Figure 4K,L,M,N) but did not express after the
first-stage induction. In contrast, non-induced hfBMSCs
did not express insulin and c-peptide (Figure 4O,P,Q,R).
The single cells from the digestion of islet-like cell clus-
ters following the three-stage induction adhered during
Figure 3 Dithizone staining and quantitative polymerase chain reaction analysis of islet-like cell clusters from bone marrow mesenchymal
stem cells of human first-trimester abortus. (A) Islet-like cell clusters were positive for dithizone staining in the nonadherent induction group
(a) and the adherent induction group (b), similar to those of fetal pancreatic islets (c), whereas non-induced bone marrow mesenchymal
stem cells of human first-trimester abortus were negative for dithizone (d). (B) Expression levels of Pdx1, Ngn3, Pax4, NeuroD1, Nkx2.2,
Nkx6.1, PCSK1, insulin, glucagon, SST and PP genes in fluorescent quantitative reverse transcriptase-polymerase chain reaction test. The islet-like
cell clusters expressed significantly more Ngn3 and Pax4, and significantly less insulin, glucagon, SST and PP than fetal pancreatic islets (P< 0.01, n= 10).
The expressions of all the genes were not different between the nonadherent induction group and the adherent induction group (P> 0.05, n= 10).
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for insulin, glucagon, SST and PP (Figure 5). The posi-
tive cell percentages for insulin, glucagon, SST and PP
were successively 45.79 ± 5.87%, 7.12 ± 2.15%, 6.33 ±
2.86% and 4.54 ± 1.54% in the nonadherent induction
group (n = 10), and were 43.42 ± 6.81%, 8.35 ± 2.72%,
5.38 ± 2.13% and 3.66 ± 1.32% in the adherent induc-
tion group (n = 10) respectively. The percentages of each
kind of positive cells were not different between the nonad-
herent induction group and the adherent induction
group (all P > 0.05, n = 10). In addition, the differenti-
ation rate of hfBMSCs towards IPCs (the cell clustering
rate × the percentage of IPCs in islet-like cell clusters) was
calculated as 29.80 ± 3.95% in the nonadherent induction
group, which was significantly higher than the differenti-
ation rate (18.40 ± 2.08%) in the adherent induction group
(P < 0.01, n = 10).In vitro insulin and C-peptide release in response to a
glucose challenge
The results of glucose challenge (Figure 6) indicated that
the islet-like cell clusters from the nonadherent inductiongroup and the adherent induction group all released insu-
lin and c-peptide at significantly higher levels than those
of the non-induction control group (all P < 0.01, n = 10).
The results also indicated that the insulin and c-peptide
releases of the islet-like cell clusters in response to glucose
challenge occurred in a concentration-dependent manner
because there was significant difference of each release
among different glucose levels (all P < 0.01, n = 10). Finally,
the release of insulin and c-peptide from the islet-like cell
clusters in the nonadherent induction group and the ad-
herent induction group was much less than those of fetal
pancreatic islets (all P < 0.01, n = 10), and they were no dif-
ferent between the nonadherent induction group and the
adherent induction group (all P > 0.05, n = 10).Effects of islet-like cell clusters to treat diabetic mice
After STZ injection, 26 of 35 (74%) of the nude mice be-
came eligible diabetic models. Following transplantation
with islet-like cell clusters, in the nonadherent induction
group the blood glucose levels of 10 diabetic mice all
sank to normal levels within 12 days, but the blood glu-
cose levels of three mice whose testes was removed
Figure 4 Immunofluorescence assay of whole islet-like cell clusters. The strongest expression of nestin is in islet-like cell clusters after the
first-stage induction in the nonadherent induction group (A), (B), (C) and the adherent induction group (D), (E), (F). The strongest expression of
insulin and c-peptide is in islet-like cell clusters after the third-stage induction in the nonadherent induction group (G), (H), (I), (J) and the adherent
induction group (K), (L), (M), (N). Non-induced bone marrow mesenchymal stem cells of human first-trimester abortus were negative for insulin
and c-peptide (O), (P), (Q), (R).
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within another 45 days; the remaining seven mice with-
out the removal of xenograft maintained normal blood
glucose values for at least 80 days (Figure 7A) and
gained body weight slightly (Figure 7B). The transplant-
ation effects in the adherent induction group were simi-
lar to those in the nonadherent induction group. In the
non-induction control group, six diabetic mice main-
tained high blood glucose levels (>18 mmol/l) after
hfBMSC transplantation, lost their body weight continu-
ously and died within 45 days after the transplantation,and so did the three mice with removal of their testes
28 days post transplantation.
The results of the intraperitoneal glucose tolerance test
(Figure 7C) indicated that the islet-like cell clusters from
the nonadherent induction group and the adherent induc-
tion group were functional, and they were indeed respon-
sive to a glucose challenge in vivo, but were not as
effective as native pancreatic beta-cells in terms of restor-
ing normoglycemia. The cells’ effects on the restoration of
normoglycemia were similar between the nonadherent in-
duction group and the adherent induction group.
Figure 5 Immunofluorescence assay of single cells from islet-like cell clusters. On enzymatic dispersion and reculture in lysine-coated plastic
dishes, the single cells from islet-like cell clusters adhered and expressed insulin (A), (B), (C), (D), glucagon (E), (F), (G), (H), SST (I), (J), (K), (L)
and PP (M), (N), (O), (P) respectively.
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gray-scale image) with red fluoroscope showed that the
CM-DiI-labeled cells mainly distributed in the interstitial tis-
sue between seminiferous tubules in the graft (Figure 8B,F,J).
The immunofluorescent examination of the dewaxed
sections indicated that the CM-DiI-labeled red cells in
interstitial tissue were positive to human insulin in the
nonadherent induction group (green, Figure 8C) and the
adherent induction group (green, Figure 8G) instead of
those in the non-induction control group (Figure 8K), dis-
playing that the insulin was produced by the transplanted
islet-like cell clusters instead of by non-induced hfBMSCs.
Discussion
Nonadherent induction strategies and principle
BMSCs are a type of cells with strong adhesion ten-
dency. Inducing such cells into cell clusters in lysine-
coated plastic dishes is difficult. In this study, hfBMSCs
in noncoated plastic dishes (under a nonadherent state)
were more efficiently induced into functional pancreatic
islet-like cell clusters than those in lysine-coated dishes
(under an adherent state) using a three-stage induction
procedure. The reason for this difference might be that
nonadherent induction in noncoated dishes not only fa-
cilitated the contact of hfBMSCs with inducers but also
provided a good opportunity for the chemotacticmovement, aggregation and clustering of hfBMSCs. Cells
in cell clusters, affected by surrounding cells via para-
crine, easily coordinated each other and differentiated.
Chang and colleagues showed that human BMSCs cen-
trifuged into cell pellets more easily differentiated to-
wards IPCs than those under a monolayer [8]. Studies
have shown that cell–cell contact between pancreatic
beta-cells is important for maintaining their survival and
increasing insulin secretion [24]. In the present study,
there were IPCs only in the islet-like cell clusters,
whereas single cells in adherent growth did not differen-
tiate towards target cells under the same induction ac-
cording to their shape and immunofluorescence assay
(Figure 4), proving that the environment within the cell
clusters was able to promote cell differentiation.
Nestin, a marker of neural stem cells, is also expressed
by cells located in the epithelium of the pancreatic prim-
ordium. Nestin-positive cells generate the cells of the
endocrine and exocrine lineages [25,26], and nestin-
positive stem cells from mouse embryonic stem cells can
be induced into insulin-positive and c-peptide-positive
cells [27]. The newest research indicated that nestin
plays pivotal roles as an intermediate regulator govern-
ing both stemness and differentiation of stem cells in the
process of their differentiation into IPCs [28]. In this
study, we efficiently induced hfBMSCs first into nestin-
Figure 6 Insulin and C-peptide release by islet-like cell clusters.
Radioimmunoassay results show that the release of insulin (A) and
c-peptide (B) is significantly different between the nonadherent
induction group and the non-induction control group, between
the nonadherent induction group and the positive control group,
and between the different glucose levels in the nonadherent induction
group (all at P < 0.01, n = 10), but were not different between the
nonadherent induction group and the adherent induction group
(P > 0.05, n = 10).
Figure 7 Effects of xenograft with islet-like cell clusters on the
recovery of streptozocin-induced diabetic mice. In the
nonadherent induction group, the blood glucose levels of 10
diabetic mice fell to normal within 2 weeks following the
transplantation, but three of the 10 mice regained hyperglycemia
when their xenograft was removed 28 days post transplantation and
all died within 45 days after the removal; the remaining seven mice
without the removal of xenograft maintained normal levels of blood
glucose for at least 80 days (A) and gained body weight slightly
(B). The intraperitoneal glucose tolerance test indicated that the
islet-like cell clusters had a normal glucose clearance rate after
transplantation, but were not as effective as native pancreatic
beta-cells (C). The effects of xenograft in the adherent induction
group are similar to those in the nonadherent induction group. In
the non-induction control group, six diabetic mice maintained
high blood glucose levels (>18 mmol/l) after bone marrow mesenchymal
stem cell of human first-trimester abortus transplantation, lost their body
weight continuously and died within 45 days after the transplantation,
and so did the mice with removal of their testes 28 days post
transplantation.
Zhang and Dou Stem Cell Research & Therapy 2014, 5:66 Page 10 of 13
http://stemcellres.com/content/5/3/66positive multipotential cell clusters, then into pancreatic
islet-like cell clusters and finally into functional islet-like
cell clusters (Figures 4 and 6) in noncoated plastic dishes
using the three-stage induction procedure. However, the
characteristics of nestin-positive cells are still debatable.
Differentiation effects of hfBMSCs after nonadherent induction
In this study, 65.08 ± 2.98% of the hfBMSCs under nonad-
herent induction differentiated into pancreatic islet-like
cell clusters, which is significantly higher than their
clustering rate (42.37 ± 3.70%) under adherent induc-
tion (P < 0.01, n = 10). The differentiation rate of hfBMSCs
towards IPCs is 29.80 ± 3.95% in the nonadherent induc-
tion group, which is significantly higher than the differenti-
ation rate (18.40 ± 2.08%) in the adherent induction group
(P < 0.01, n = 10), as well as higher than the differentiation
rate (10 to 20%) of mouse BMSCs in adherence towards
IPCs reported by Tang and colleagues [4] and the differen-
tiation rate (19.8%) of rat BMSCs in adherence towards
Figure 8 Immunofluorescence examination of dewaxed sections of the grafts. Red CM-DiI-labeled cells in a graft section (A) in the nonadherent
induction group were visualized only in the interstitial tissue among the seminiferous tubules (B) and showed green fluorophore (C) (merged in
(D)) after staining with human insulin antibody under a fluoroscope. A similar phenomenon occurred in a graft section in the adherent induction
group (E), (F), (G), (H), whereas CM-DiI-labeled cells in the non-induction control group did not express insulin (I), (J), (K), (L).
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dicate that nonadherent induction in noncoated plastic
dishes can greatly promote BMSCs to form pancreatic
islet-like cell clusters, thereby improving the differentiation
rate of BMSCs towards IPCs.
In comparison with the fetal pancreatic islets, the islet-
like cell clusters from hfBMSCs expressed more Ngn3
and Pax4, the markers of early stage beta-cell develop-
ment, and secreted relatively lower insulin, glucagon,
SST and PP (all P < 0.01, n = 10), indicating that their dif-
ferentiation was not full in vitro.
Effects of islet-like cell clusters on mouse diabetic
treatment
Although some attempts have been made to treat dia-
betes in an animal model with induced BMSCs in adher-
ence, the results are not ideal. Wu and colleagues
reported that the glucose levels of STZ-induced diabetic
rats began decreasing at day 6 after the allograft with
5 × 106 induced rat BMSCs in adherence, and remained
below 15 mmol/l from day 12 to day 16 post transplant-
ation but elevated again after day 20 [6]. The research by
Hisanaga and colleagues showed that the plasma glucose
level of STZ-induced diabetic mice markedly fell after
the allograft with 5 × 107 induced mouse BMSCs inadherence and the effect continued for at least 4 weeks
[7]. Xie and colleagues ameliorated the diabetic condi-
tions of STZ-treated mice by the transplantation of IPCs
derived from BMSCs [9]. In this study, the hypergly-
cemia of diabetic nude mice was normalized by trans-
planting 600 pancreatic islet-like cell clusters (about
7.2 × 105 cells) from hfBMSCs. The blood glucose levels
of three mice rose again after removal of the grafts while
seven mice without removal of the graft maintained nor-
mal blood glucose levels for at least 80 days (Figure 7A),
indicating that the transplanted cells were responsible for
the cure of hyperglycemia. This observation was further
confirmed by colabeling of CM-DiI and immunofluor-
escent antibodies against human insulin in the grafts,
which demonstrated that the transplanted cells pro-
duced functional human insulin in vivo (Figure 8).
In addition, in this study the islet-like cell clusters
were transplanted in the testes of model animals be-
cause not only there is a strong blood circulation in the
testis but also operation of cell transplantation and
withdrawal of the graft aimed at the testis is easier than
that aimed at other organs, such as a renal subcapsular
graft. The transplanted islet-like cell clusters normal-
ized the blood glucose levels of diabetic model mice
12 days after transplantation (Figure 7A), implying that
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ation, maturation and gradual functioning in vivo.
BMSCs from human first-trimester abortus
We are not advocating carrying out abortions for the
single purpose of obtaining human fetal BMSCs, but a
human abortus is a source of obtaining a variety of fetal
stem cells, especially in some countries with family plan-
ning policy or birth-control policy. Certainly, such an
approach may be controversial in some other countries.
The properties of hfBMSCs range between those of em-
bryonic stem cells and adult stem cells, but hfBMSCs
form no tumors in mice [29] whereas embryonic stem
cells induced towards IPCs still form tumors in mice
[30,31]. Thus hfBMSCs are an ideal type of seed cell for
research on human tissue engineering and regeneration
medicine.
Conclusions
This study demonstrates that nonadherent induction can
greatly promote BMSCs to form pancreatic islet-like cell
clusters, thereby improving the differentiation efficiency of
BMSCs towards IPCs.
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